Individual Bioequivalence: Attractive in Principle, Difficult in Practice
dc.contributor.author | Midha, Kamal K. | en_US |
dc.contributor.author | Endrenyi, Laszlo | en_US |
dc.contributor.author | Amidon, Gordon L. | en_US |
dc.contributor.author | Skelly, Jerome P. | en_US |
dc.date.accessioned | 2006-09-08T19:17:28Z | |
dc.date.available | 2006-09-08T19:17:28Z | |
dc.date.issued | 1998-09 | en_US |
dc.identifier.citation | Endrenyi, Laszlo; Amidon, Gordon L.; Midha, Kamal K.; Skelly, Jerome P.; (1998). "Individual Bioequivalence: Attractive in Principle, Difficult in Practice." Pharmaceutical Research 15(9): 1321-1325. <http://hdl.handle.net/2027.42/41468> | en_US |
dc.identifier.issn | 0724-8741 | en_US |
dc.identifier.issn | 1573-904X | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/41468 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=9755880&dopt=citation | en_US |
dc.format.extent | 464909 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Kluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Media | en_US |
dc.subject.other | Pharmacology/Toxicology | en_US |
dc.subject.other | Biomedicine | en_US |
dc.subject.other | Drug Regulation | en_US |
dc.subject.other | Biochemistry, General | en_US |
dc.subject.other | Pharmacy | en_US |
dc.subject.other | Medical Law | en_US |
dc.subject.other | Average Bioequivalence | en_US |
dc.subject.other | Individual Bioequivalence | en_US |
dc.subject.other | Biomedical Engineering | en_US |
dc.subject.other | Generic Drugs | en_US |
dc.title | Individual Bioequivalence: Attractive in Principle, Difficult in Practice | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan, USA | en_US |
dc.contributor.affiliationother | University of Saskatchewan, USA | en_US |
dc.contributor.affiliationother | Department of Pharmacology, University of Toronto, Toronto, Ontario, M5S 1A8, Canada | en_US |
dc.contributor.affiliationother | University of Cincinnati, USA | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 9755880 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/41468/1/11095_2004_Article_303981.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1023/A:1011972732530 | en_US |
dc.identifier.source | Pharmaceutical Research | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.